Skip to main content

Chronic Rhinosinusitis

2
Pipeline Programs
7
Companies
10
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Airiver Medical
Airiver MedicalMN - Brooklyn Park
2 programs
2
Airiver Nasal Drug Coated BalloonPhase 11 trial
paclitaxel-coated balloonPhase 11 trial
Active Trials
NCT05883462Active Not Recruiting45Est. Dec 2029
NCT07290140Not Yet Recruiting300Est. Mar 2031
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
4 programs
Checklist introduction / PauseN/A1 trial
Determinants of Medical and Surgical Treatment Outcomes in Chronic SinusitisN/A1 trial
Determinants of Surgical Outcomes in Chronic SinusitisN/A1 trial
oral corticosteroid taperN/A1 trial
Active Trials
NCT01499719Completed100Est. Dec 2012
NCT01332136Completed966Est. Mar 2016
NCT00799097Completed516Est. Dec 2009
+1 more trials
Medtronic
MedtronicNJ - Phillipsburg
1 program
Electromagnetic Sinus Dilation SystemN/A1 trial
Active Trials
NCT02284347Completed51Est. May 2015
Tivic
TivicSAN ANTONIO, TX
1 program
Microcurrent TENS deviceN/A1 trial
Active Trials
NCT05198518Completed60Est. Apr 2024
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Relieva Balloon Sinuplasty™ SystemN/A1 trial
Active Trials
NCT01455948Terminated25Est. Nov 2012
Chia Tai TianQing Pharmaceutical Group
1 program
300mg/600mg of TQH2722 injectionPHASE_21 trial
Active Trials
NCT06439381Recruiting120Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Chia Tai TianQing Pharmaceutical Group300mg/600mg of TQH2722 injection
Airiver MedicalAiriver Nasal Drug Coated Balloon
Airiver Medicalpaclitaxel-coated balloon
TivicMicrocurrent TENS device
MedtronicElectromagnetic Sinus Dilation System
Integra LifeSciencesRelieva Balloon Sinuplasty™ System
Oregon TherapeuticsChecklist introduction / Pause
Oregon TherapeuticsDeterminants of Medical and Surgical Treatment Outcomes in Chronic Sinusitis
Oregon Therapeuticsoral corticosteroid taper
Oregon TherapeuticsDeterminants of Surgical Outcomes in Chronic Sinusitis

Clinical Trials (10)

Total enrollment: 2,183 patients across 10 trials

NCT06439381Chia Tai TianQing Pharmaceutical Group300mg/600mg of TQH2722 injection

Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

Start: Jul 2024Est. completion: Jun 2026120 patients
Phase 2Recruiting
NCT05883462Airiver MedicalAiriver Nasal Drug Coated Balloon

Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)

Start: Jun 2023Est. completion: Dec 202945 patients
Phase 1Active Not Recruiting
NCT07290140Airiver Medicalpaclitaxel-coated balloon

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Start: Mar 2026Est. completion: Mar 2031300 patients
N/ANot Yet Recruiting
NCT05198518TivicMicrocurrent TENS device

Microcurrent Device (TIVIC Health)

Start: Mar 2022Est. completion: Apr 202460 patients
N/ACompleted
NCT02284347MedtronicElectromagnetic Sinus Dilation System

NuVent™ Revision Study

Start: Dec 2014Est. completion: May 201551 patients
N/ACompleted
NCT01455948Integra LifeSciencesRelieva Balloon Sinuplasty™ System

Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis

Start: Feb 2012Est. completion: Nov 201225 patients
N/ATerminated
NCT01499719Oregon TherapeuticsChecklist introduction / Pause

Surgery Checklist and Process Improvement Surrounding Endoscopic Sinus Surgery

Start: Dec 2011Est. completion: Dec 2012100 patients
N/ACompleted
NCT01332136Oregon TherapeuticsDeterminants of Medical and Surgical Treatment Outcomes in Chronic Sinusitis

Determinants of Medical and Surgical Treatment Outcomes in Chronic Sinusitis

Start: Apr 2011Est. completion: Mar 2016966 patients
N/ACompleted
NCT01255683Oregon Therapeuticsoral corticosteroid taper

Oral Steroid Treatment for Chronic Rhinosinusitis

Start: Dec 2010Est. completion: Nov 20110
N/AWithdrawn
NCT00799097Oregon TherapeuticsDeterminants of Surgical Outcomes in Chronic Sinusitis

Determinants of Surgical Outcomes in Chronic Sinusitis

Start: Jul 2004Est. completion: Dec 2009516 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,183 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.